UniProt ID | APOB_MOUSE | |
---|---|---|
UniProt AC | E9Q414 | |
Protein Name | Apolipoprotein B-100 | |
Gene Name | Apob | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 4505 | |
Subcellular Localization | Cytoplasm . Secreted . | |
Protein Description | Apolipoprotein B is a major protein constituent of chylomicrons (apo B-48), LDL (apo B-100) and VLDL (apo B-100). Apo B-100 functions as a recognition signal for the cellular binding and internalization of LDL particles by the apoB/E receptor.. | |
Protein Sequence | MGPRKPALRTPLLLLFLLLFLDTSVWAQDEVLENLSFSCPKDATRFKHLRKYVYNYEAESSSGVQGTADSRSATKINCKVELEVPQICGFIMRTNQCTLKEVYGFNPEGKALMKKTKNSEEFAAAMSRYELKLAIPEGKQIVLYPDKDEPKYILNIKRGIISALLVPPETEEDQQELFLDTVYGNCSTQVTVNSRKGTVPTEMSTERNLQQCDGFQPISTSVSPLALIKGLVHPLSTLISSSQTCQYTLDPKRKHVSEAVCDEQHLFLPFSYKNKYGIMTRVTQKLSLEDTPKINSRFFSEGTNRMGLAFESTKSTSSPKQADAVLKTLQELKKLSISEQNAQRANLFNKLVTELRGLTGEAITSLLPQLIEVSSPITLQALVQCGQPQCYTHILQWLKTEKAHPLLVDIVTYLMALIPNPSTQRLQEIFNTAKEQQSRATLYALSHAVNSYFDVDHSRSPVLQDIAGYLLKQIDNECTGNEDHTFLILRVIGNMGRTMEQVMPALKSSVLSCVRSTKPSLLIQKAALQALRKMELEDEVRTILFDTFVNGVAPVEKRLAAYLLLMKNPSSSDINKIAQLLQWEQSEQVKNFVASHIANILNSEELYVQDLKVLIKNALENSQFPTIMDFRKFSRNYQISKSASLPMFDPVSVKIEGNLIFDPSSYLPRESLLKTTLTVFGLASLDLFEIGLEGKGFEPTLEALFGKQGFFPDSVNKALYWVNGRVPDGVSKVLVDHFGYTTDGKHEQDMVNGIMPIVDKLIKDLKSKEIPEARAYLRILGKELSFVRLQDLQVLGKLLLSGAQTLQGIPQMVVQAIREGSKNDLFLHYIFMDNAFELPTGAGLQLQVSSSGVFTPGIKAGVRLELANIQAELVAKPSVSLEFVTNMGIIIPDFAKSSVQMNTNFFHESGLEARVALKAGQLKVIIPSPKRPVKLFSGSNTLHLVSTTKTEVIPPLVENRQSWSTCKPLFTGMNYCTTGAYSNASSTESASYYPLTGDTRYELELRPTGEVEQYSATATYELLKEDKSLVDTLKFLVQAEGVQQSEATVLFKYNRRSRTLSSEVLIPGFDVNFGTILRVNDESAKDKNTYKLILDIQNKKITEVSLVGHLSYDKKGDGKIKGVVSIPRLQAEARSEVHTHWSSTKLLFQMDSSATAYGSTISKRVTWRYDNEIIEFDWNTGTNVDTKKVASNFPVDLSHYPRMLHEYANGLLDHRVPQTDVTFRDMGSKLIVATNTWLQMATRGLPYPQTLQDHLNSLSELNLLKMGLSDFHIPDNLFLKTDGRVKYTMNRNKINIDIPLPLGGKSSKDLKMPESVRTPALNFKSVGFHLPSREVQVPTFTIPKTHQLQVPLLGVLDLSTNVYSNLYNWSASYTGGNTSRDHFSLQAQYRMKTDSVVDLFSYSVQGSGETTYDSKNTFTLSCDGSLHHKFLDSKFKVSHVEKFGNSPVSKGLLTFETSSALGPQMSATVHLDSKKKQHLYVKDIKVDGQFRASSFYAQGKYGLSCERDVTTGQLSGESNMRFNSTYFQGTNQIVGMYQDGALSITSTSDLQDGIFKNTASLKYENYELTLKSDSSGQYENFAASNKLDVTFSTQSALLRSEHQANYKSLRLVTLLSGSLTSQGVELNADILGTDKINTGAHKATLKIARDGLSTSATTNLKYSPLLLENELNAELGLSGASMKLSTNGRFKEHHAKFSLDGRAALTEVSLGSIYQAMILGADSKNIFNFKLSREGLRLSNDLMGSYAEMKLDHTHSLNIAGLSLDFFSKMDNIYSGDKFYKQNFNLQLQPYSFITTLSNDLRYGALDLTNNGRFRLEPLKLNVGGNFKGTYQNNELKHIYTISYTDLVVASYRADTVAKVQGVEFSHRLNADIEGLTSSVDVTTSYNSDPLHFNNVFHFSLAPFTLGIDTHTSGDGKLSFWGEHTGQLYSKFLLKAEPLALIVSHDYKGSTSHSLPYESSISTALEHTVSALLTPAEQTSTWKFKTKLNDKVYSQDFEAYNTKDKIGVELSGRADLSGLYSPIKLPFFYSEPVNVLNGLEVNDAVDKPQEFTIIAVVKYDKNQDVHTINLPFFKSLPDYLERNRRGMISLLEAMRGELQRLSVDQFVRKYRAALSRLPQQIHHYLNASDWERQVAGAKEKITSFMENYRITDNDVLIAIDSAKINFNEKLSQLETYAIQFDQYIKDNYDPHDLKRTIAEIIDRIIEKLKILDEQYHIRVNLAKSIHNLYLFVENVDLNQVSSSNTSWIQNVDSNYQVRIQIQEKLQQLRTQIQNIDIQQLAAEVKRQMDAIDVTMHLDQLRTAILFQRISDIIDRVKYFVMNLIEDFKVTEKINTFRVIVRELIEKYEVDQHIQVLMDKSVELAHRYSLSEPLQKLSNVLQRIEIKDYYEKLVGFIDDTVEWLKALSFKNTIEELNRLTDMLVKKLKAFDYHQFVDKTNSKIREMTQRINAEIQALKLPQKMEALKLLVEDFKTTVSNSLERLKDTKVTVVIDWLQDILTQMKDHFQDTLEDVRDRIYQMDIQRELEHFLSLVNQVYSTLVTYMSDWWTLTAKNITDFAEQYSIQNWAESIKVLVEQGFIVPEMQTFLWTMPAFEVSLRALQEGNFQTPVFIVPLTDLRIPSIRINFKMLKNIKIPLRFSTPEFTLLNTFHVHSFTIDLLEIKAKIIRTIDQILSSELQWPLPEMYLRDLDVVNIPLARLTLPDFHVPEITIPEFTIPNVNLKDLHVPDLHIPEFQLPHLSHTIEIPAFGKLHSILKIQSPLFILDANANIQNVTTSGNKAEIVASVTAKGESQFEALNFDFQAQAQFLELNPHPPVLKESMNFSSKHVRMEHEGEIVFDGKAIEGKSDTVASLHTEKNEVEFNNGMTVKVNNQLTLDSHTKYFHKLSVPRLDFSSKASLNNEIKTLLEAGHVALTSSGTGSWNWACPNFSDEGIHSSQISFTVDGPIAFVGLSNNINGKHLRVIQKLTYESGFLNYSKFEVESKVESQHVGSSILTANGRALLKDAKAEMTGEHNANLNGKVIGTLKNSLFFSAQPFEITASTNNEGNLKVGFPLKLTGKIDFLNNYALFLSPRAQQASWQASTRFNQYKYNQNFSAINNEHNIEASIGMNGDANLDFLNIPLTIPEINLPYTEFKTPLLKDFSIWEETGLKEFLKTTKQSFDLSVKAQYKKNSDKHSIVVPLGMFYEFILNNVNSWDRKFEKVRNNALHFLTTSYNEAKIKVDKYKTENSLNQPSGTFQNHGYTIPVVNIEVSPFAVETLASSHVIPTAISTPSVTIPGPNIMVPSYKLVLPPLELPVFHGPGNLFKFFLPDFKGFNTIDNIYIPAMGNFTYDFSFKSSVITLNTNAGLYNQSDIVAHFLSSSSFVTDALQYKLEGTSRLMRKRGLKLATAVSLTNKFVKGSHDSTISLTKKNMEASVRTTANLHAPIFSMNFKQELNGNTKSKPTVSSSIELNYDFNSSKLHSTATGGIDHKFSLESLTSYFSIESFTKGNIKSSFLSQEYSGSVANEANVYLNSKGTRSSVRLQGASKVDGIWNVEVGENFAGEATLQRIYTTWEHNMKNHLQVYSYFFTKGKQTCRATLELSPWTMSTLLQVHVSQLSSLLDLHHFDQEVILKANTKNQKISWKGGVQVESRVLQHNAQFSNDQEEIRLDLAGSLDGQLWDLEAIFLPVYGKSLQELLQMDGKRQYLQASTSLLYTKNPNGYLLSLPVQELADRFIIPGIKLNDFSGVKIYKKLSTSPFALNLTMLPKVKFPGIDLLTQYSTPEGSSVPIFEATIPEIHLTVSQFTLPKSLPVGNTVFDLNKLANMIADVDLPSVTLPEQTIVIPPLEFSVPAGIFIPFFGELTARAGMASPLYNVTWSAGWKTKADHVETFLDSMCTSTLQFLEYALKVVETHKIEEDLLTYNIKGTLQHCDFNVEYNEDGLFKGLWDWQGEAHLDITSPALTDFHLYYKEDKTSLSASAASSTIGTVGLDSSTDDQSVELNVYFHPQSPPEKKLSIFKTEWRYKESDGERYIKINWEEEAASRLLGSLKSNVPKASKAIYDYANKYHLEYVSSELRKSLQVNAEHARRMVDEMNMSFQRVARDTYQNLYEEMLAQKSLSIPENLKKRVLDSIVHVTQKYHMAVMWLMDSFIHFLKFNRVQFPGYAGTYTVDELYTIVMKETKKSLSQLFNGLGNLLSYVQNQVEKSRLINDITFKCPFFSKPCKLKDLILIFREELNILSNIGQQDIKFTTILSSLQGFLERVLDIIEEQIKCLKDNESTCVADHINMVFKIQVPYAFKSLREDIYFVLGEFNDFLQSILQEGSYKLQQVHQYMKALREEYFDPSMVGWTVKYYEIEENMVELIKTLLVSFRDVYSEYSVTAADFASKMSTQVEQFVSRDIREYLSMLTDINGKWMEKIAELSIVAKETMKSWVTAVAKIMSDYPQQFHSNLQDFSDQLSSYYEKFVGESTRLIDLSIQNYHVFLRYITELLRKLQVATANNVSPYIKLAQGELMITF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
34 | N-linked_Glycosylation | AQDEVLENLSFSCPK CCHHHHHHCCCCCCC | - | ||
157 | Ubiquitination | PKYILNIKRGIISAL CCEEEEECCCCEEEE | 22790023 | ||
185 | N-linked_Glycosylation | FLDTVYGNCSTQVTV HHHHHHCCCEEEEEE | - | ||
320 | Ubiquitination | TKSTSSPKQADAVLK CCCCCCHHHHHHHHH | 22790023 | ||
434 | Ubiquitination | QEIFNTAKEQQSRAT HHHHHHHHHHHHHHH | 22790023 | ||
458 | Phosphorylation | SYFDVDHSRSPVLQD HHCCCCCCCCHHHHH | - | ||
460 | Phosphorylation | FDVDHSRSPVLQDIA CCCCCCCCHHHHHHH | - | ||
498 | Phosphorylation | VIGNMGRTMEQVMPA ECCCCCCCHHHHHHH | - | ||
525 | Ubiquitination | KPSLLIQKAALQALR CHHHHHHHHHHHHHH | 22790023 | ||
607 | Phosphorylation | ILNSEELYVQDLKVL HCCCHHHHHHHHHHH | - | ||
622 | Phosphorylation | IKNALENSQFPTIMD HHHHHHCCCCCCHHC | - | ||
626 | Phosphorylation | LENSQFPTIMDFRKF HHCCCCCCHHCHHHH | - | ||
731 | Phosphorylation | GRVPDGVSKVLVDHF CCCCCCCCEEEEEEC | 23737553 | ||
782 | Ubiquitination | AYLRILGKELSFVRL HHHHHHCCCCCCEEH | 22790023 | ||
947 | Phosphorylation | NTLHLVSTTKTEVIP CEEEEEEECCCCCCC | - | ||
983 | N-linked_Glycosylation | CTTGAYSNASSTESA CCCCCCCCCCCCCEE | - | ||
1163 | Acetylation | AYGSTISKRVTWRYD CCCCCCCCCEEEECC | 51082261 | ||
1305 | Ubiquitination | IPLPLGGKSSKDLKM ECCCCCCCCCCCCCC | 22790023 | ||
1368 | N-linked_Glycosylation | NVYSNLYNWSASYTG CHHHHCCCCCCCCCC | - | ||
1377 | N-linked_Glycosylation | SASYTGGNTSRDHFS CCCCCCCCCCCCCEE | - | ||
1523 | N-linked_Glycosylation | GESNMRFNSTYFQGT CCCCCEEECEEECCC | - | ||
1655 | Phosphorylation | ARDGLSTSATTNLKY ECCCCCCCCCCCCCC | 25777480 | ||
1657 | Phosphorylation | DGLSTSATTNLKYSP CCCCCCCCCCCCCCC | 25777480 | ||
1658 | Phosphorylation | GLSTSATTNLKYSPL CCCCCCCCCCCCCCC | 25777480 | ||
1662 | Phosphorylation | SATTNLKYSPLLLEN CCCCCCCCCCCEECC | 25777480 | ||
1663 | Phosphorylation | ATTNLKYSPLLLENE CCCCCCCCCCEECCH | 25777480 | ||
1678 | Phosphorylation | LNAELGLSGASMKLS HHHHCCCCCCCCEEC | 25777480 | ||
1698 | Phosphorylation | KEHHAKFSLDGRAAL CCEEEEECCCCHHHH | 24719451 | ||
1828 | Ubiquitination | LNVGGNFKGTYQNNE ECCCCCCCCEECCCC | 22790023 | ||
1991 | Ubiquitination | FKTKLNDKVYSQDFE EEECCCCCEECCCCC | 22790023 | ||
2005 | Acetylation | EAYNTKDKIGVELSG CCCCCCCCCCEEECC | - | ||
2142 | Phosphorylation | AGAKEKITSFMENYR HHHHHHHHHHHHHCC | 30635358 | ||
2143 | Phosphorylation | GAKEKITSFMENYRI HHHHHHHHHHHHCCC | 30635358 | ||
2148 | Phosphorylation | ITSFMENYRITDNDV HHHHHHHCCCCCCCE | 30635358 | ||
2196 | Phosphorylation | DPHDLKRTIAEIIDR CHHHHHHHHHHHHHH | 25159016 | ||
2554 | N-linked_Glycosylation | WWTLTAKNITDFAEQ CEEEEECCHHHHHHH | - | ||
2608 | Phosphorylation | LQEGNFQTPVFIVPL HHHCCCCCCEEEEEC | - | ||
2622 | Phosphorylation | LTDLRIPSIRINFKM CCCCCCCCEEEEEEE | 24719451 | ||
2754 | Phosphorylation | PAFGKLHSILKIQSP CCCCHHHHHHHCCCC | 26370283 | ||
2773 | N-linked_Glycosylation | DANANIQNVTTSGNK ECCCCEEEECCCCCC | 16944957 | ||
2888 | Phosphorylation | TKYFHKLSVPRLDFS CCEEEECCCCCCCCC | 24719451 | ||
2976 | N-linked_Glycosylation | TYESGFLNYSKFEVE EECCCCCCCCEEEEE | 16944957 | ||
3095 | N-linked_Glycosylation | NQYKYNQNFSAINNE HCCCCCCCCCCCCCC | - | ||
3270 | Phosphorylation | ASSHVIPTAISTPSV HHCCCCCCCCCCCCC | 25777480 | ||
3273 | Phosphorylation | HVIPTAISTPSVTIP CCCCCCCCCCCCEEC | 25777480 | ||
3274 | Phosphorylation | VIPTAISTPSVTIPG CCCCCCCCCCCEECC | 25777480 | ||
3276 | Phosphorylation | PTAISTPSVTIPGPN CCCCCCCCCEECCCC | 25777480 | ||
3278 | Phosphorylation | AISTPSVTIPGPNIM CCCCCCCEECCCCEE | 25777480 | ||
3288 | Phosphorylation | GPNIMVPSYKLVLPP CCCEECCCEEEEECC | 25777480 | ||
3289 | Phosphorylation | PNIMVPSYKLVLPPL CCEECCCEEEEECCC | 25777480 | ||
3331 | N-linked_Glycosylation | IYIPAMGNFTYDFSF EEECCCCCEEEEEEE | - | ||
3353 | N-linked_Glycosylation | NTNAGLYNQSDIVAH ECCCCCCCHHHHHHH | - | ||
3460 | N-linked_Glycosylation | IELNYDFNSSKLHST EEEEECCCCCCCEEE | - | ||
3860 | N-linked_Glycosylation | GMASPLYNVTWSAGW CCCCCCEEECCCCCC | - | ||
4013 | Phosphorylation | TEWRYKESDGERYIK EEEEEECCCCCEEEE | - | ||
4018 | Phosphorylation | KESDGERYIKINWEE ECCCCCEEEEEECHH | - | ||
4057 | Phosphorylation | ANKYHLEYVSSELRK HHHHHHHHHCHHHHH | - | ||
4311 | Phosphorylation | QSILQEGSYKLQQVH HHHHHHCCHHHHHHH | 23140645 | ||
4312 | Phosphorylation | SILQEGSYKLQQVHQ HHHHHCCHHHHHHHH | 23140645 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of APOB_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of APOB_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of APOB_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
APOA1_HUMAN | APOA1 | physical | 16204232 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...